{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:34:55Z","timestamp":1791304495053,"version":"4.3.1"},"reference-count":79,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:00:00Z","timestamp":1718496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Glucocerebrosidase (GCase) is a lysosomal enzyme that catalyzes the breakdown of glucosylceramide in the presence of its activator saposin C (SapC). SapC arises from the proteolytical cleavage of prosaposin (encoded by PSAP gene), which gives rise to four saposins. GCase is targeted to the lysosomes by LIMP-2, encoded by SCARB2 gene. GCase deficiency causes Gaucher Disease (GD), which is mainly due to biallelic pathogenetic variants in the GCase-encoding gene, GBA1. However, impairment of GCase activity can be rarely caused by SapC or LIMP-2 deficiencies. We report a new case of LIMP-2 deficiency and a new case of SapC deficiency (missing all four saposins, PSAP deficiency), and measured common biomarkers of GD and GCase activity. Glucosylsphingosine and chitotriosidase activity in plasma were increased in GCase deficiencies caused by PSAP and GBA1 mutations, whereas SCARB2-linked deficiency showed only Glucosylsphingosine elevation. GCase activity was reduced in fibroblasts and leukocytes: the decrease was sharper in GBA1- and SCARB2-mutant fibroblasts than PSAP-mutant ones; LIMP-2-deficient leukocytes displayed higher residual GCase activity than GBA1-mutant ones. Finally, we demonstrated that GCase mainly undergoes proteasomal degradation in LIMP-2-deficient fibroblasts and lysosomal degradation in PSAP-deficient fibroblasts. Thus, we analyzed the differential biochemical profile of GCase deficiencies due to the ultra-rare PSAP and SCARB2 biallelic pathogenic variants in comparison with the profile observed in GBA1-linked GCase deficiency.<\/jats:p>","DOI":"10.3390\/ijms25126615","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:14:16Z","timestamp":1718622856000},"page":"6615","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Deficiency of Glucocerebrosidase Activity beyond Gaucher Disease: PSAP and LIMP-2 Dysfunctions"],"prefix":"10.3390","volume":"25","author":[{"given":"Eleonora","family":"Pavan","sequence":"first","affiliation":[{"name":"Regional Coordinator Centre for Rare Diseases, University Hospital of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5216-8719","authenticated-orcid":false,"given":"Paolo","family":"Peruzzo","sequence":"additional","affiliation":[{"name":"Regional Coordinator Centre for Rare Diseases, University Hospital of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Cattarossi","sequence":"additional","affiliation":[{"name":"Regional Coordinator Centre for Rare Diseases, University Hospital of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Bergamin","sequence":"additional","affiliation":[{"name":"Regional Coordinator Centre for Rare Diseases, University Hospital of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bordugo","sequence":"additional","affiliation":[{"name":"Regional Coordinator Centre for Rare Diseases, University Hospital of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Sechi","sequence":"additional","affiliation":[{"name":"Regional Coordinator Centre for Rare Diseases, University Hospital of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Scarpa","sequence":"additional","affiliation":[{"name":"Regional Coordinator Centre for Rare Diseases, University Hospital of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Biasizzo","sequence":"additional","affiliation":[{"name":"Clinical Pathology Division, Department of Laboratory Medicine, University Hospital Friuli Centrale ASUFC, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Colucci","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7024-8181","authenticated-orcid":false,"given":"Andrea","family":"Dardis","sequence":"additional","affiliation":[{"name":"Regional Coordinator Centre for Rare Diseases, University Hospital of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0888-7543(89)90319-4","article-title":"The Human Glucocerebrosidase Gene and Pseudogene: Structure and Evolution","volume":"4","author":"Horowitz","year":"1989","journal-title":"Genomics"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1073\/pnas.82.21.7289","article-title":"Molecular Cloning and Nucleotide Sequence of Human Glucocerebrosidase CDNA","volume":"82","author":"Sorge","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0021-9258(17)42428-8","article-title":"Nucleotide Sequence of CDNA Containing the Complete Coding Sequence for Human Lysosomal Glucocerebrosidase","volume":"261","author":"Tsuji","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"14319","DOI":"10.1016\/S0021-9258(17)38720-3","article-title":"Biosynthesis of the Lysosomal Enzyme Glucocerebrosidase","volume":"260","author":"Erickson","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"14861","DOI":"10.1016\/S0021-9258(18)82412-7","article-title":"Human Acid Beta-Glucosidase. N-Glycosylation Site Occupancy and the Effect of Glycosylation on Enzymatic Activity","volume":"268","author":"Grace","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/mgme.2000.3035","article-title":"Fate and Sorting of Acid Beta-Glucosidase in Transgenic Mammalian Cells","volume":"70","author":"Leonova","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbamcr.2008.10.016","article-title":"Sorting of Lysosomal Proteins","volume":"1793","author":"Braulke","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 Is a Receptor for Lysosomal Mannose-6-Phosphate-Independent Targeting of Beta-Glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.04.024","article-title":"The Role of Saposin C in Gaucher Disease","volume":"106","author":"Tamargo","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"30271","DOI":"10.1074\/jbc.273.46.30271","article-title":"Lysosomal Degradation on Vesicular Membrane Surfaces. Enhanced Glucosylceramide Degradation by Lysosomal Anionic Lipids and Activators","volume":"273","author":"Wilkening","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1096\/fasebj.5.3.2001789","article-title":"Saposin Proteins: Structure, Function, and Role in Human Lysosomal Storage Disorders","volume":"5","author":"Kishimoto","year":"1991","journal-title":"FASEB J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of Glucocerebrosides II. Evidence of an Enzymatic Deficiency in Gaucher\u2019s Disease","volume":"18","author":"Brady","year":"1965","journal-title":"BioChem. Biophys. Res. Commun."},{"key":"ref_13","unstructured":"Scriver, C.R., Beaudet, A.L., Valle, D., and Sly, W.S. (2001). Gaucher Disease. The Metabolic and Molecular Basis of Inherited Disease, McGraw-Hill."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.256.5058.794","article-title":"Gaucher Disease: New Molecular Approaches to Diagnosis and Treatment","volume":"256","author":"Beutler","year":"1992","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1096\/fj.15-271148","article-title":"Role of LIMP-2 in the Intracellular Trafficking of \u03b2-Glucosidase in Different Human Cellular Models","volume":"29","author":"Malini","year":"2015","journal-title":"FASEB J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2009.04.011","article-title":"Biochemical and Molecular Findings in a Patient with Myoclonic Epilepsy Due to a Mistarget of the Beta-Glucosidase Enzyme","volume":"97","author":"Dardis","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/hmg\/ddn124","article-title":"A Nonsense Mutation in the LIMP-2 Gene Associated with Progressive Myoclonic Epilepsy and Nephrotic Syndrome","volume":"17","author":"Balreira","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_18","first-page":"73","article-title":"Successful Screening for Gaucher Disease in a High-Prevalence Population in Tabuleirodo Norte (Northeastern Brazil): A Cross-Sectional Study","volume":"1","author":"Chaves","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.21765","article-title":"SCARB2 Mutations in Progressive Myoclonus Epilepsy (PME) without Renal Failure","volume":"66","author":"Dibbens","year":"2009","journal-title":"Ann. Neurol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1111\/j.1528-1167.2011.03307.x","article-title":"Clinical and Neurophysiologic Features of Progressive Myoclonus Epilepsy without Renal Failure Caused by SCARB2 Mutations","volume":"52","author":"Rubboli","year":"2011","journal-title":"Epilepsia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jns.2014.01.022","article-title":"A Novel SCARB2 Mutation in Progressive Myoclonus Epilepsy Indicated by Reduced \u03b2-Glucocerebrosidase Activity","volume":"339","author":"Zeigler","year":"2014","journal-title":"J. Neurol Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e614","DOI":"10.1212\/NXG.0000000000000614","article-title":"Miglustat Therapy for SCARB2-Associated Action Myoclonus-Renal Failure Syndrome","volume":"7","author":"Quraishi","year":"2021","journal-title":"Neurol Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2021.06.027","article-title":"A Diagnosis of Progressive Myoclonic Ataxia Guided by Blood Biomarkers","volume":"94","author":"Dubot","year":"2022","journal-title":"Park. Relat. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/brain\/awh263","article-title":"Action Myoclonus-Renal Failure Syndrome: Characterization of a Unique Cerebro-Renal Disorder","volume":"127","author":"Badhwar","year":"2004","journal-title":"Brain"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ajhg.2007.12.019","article-title":"Array-Based Gene Discovery with Three Unrelated Subjects Shows SCARB2\/LIMP-2 Deficiency Causes Myoclonus Epilepsy and Glomerulosclerosis","volume":"82","author":"Berkovic","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1684\/epd.2016.0843","article-title":"SCARB2\/LIMP2 Deficiency in Action Myoclonus-Renal Failure Syndrome","volume":"18","author":"Dibbens","year":"2016","journal-title":"Epileptic Disord."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hopfner, F., Schormair, B., Knauf, F., Berthele, A., T\u00f6lle, T.R., Baron, R., Maier, C., Treede, R.D., Binder, A., and Sommer, C. (2011). Novel SCARB2 Mutation in Action Myoclonus-Renal Failure Syndrome and Evaluation of SCARB2 Mutations in Isolated AMRF Features. BMC Neurol, 11.","DOI":"10.1186\/1471-2377-11-134"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mds.25738","article-title":"A New SCARB2 Mutation in a Patient with Progressive Myoclonus Ataxia without Renal Failure","volume":"29","author":"Perandones","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/mds.25083","article-title":"A Case of Severe Hearing Loss in Action Myoclonus Renal Failure Syndrome Resulting from Mutation in SCARB2","volume":"27","author":"Perandones","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Atasu, B., Acarl\u0131, A.N.O., Bilgic, B., Baykan, B., Demir, E., Ozluk, Y., Turkmen, A., Hauser, A.K., Guven, G., and Hanagasi, H. (2022). Genotype-Phenotype Correlations of SCARB2 Associated Clinical Presentation: A Case Report and in-Depth Literature Review. BMC Neurol, 22.","DOI":"10.1186\/s12883-022-02628-y"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.seizure.2021.03.018","article-title":"Report of Two Siblings with Action Myoclonus Renal Failure Syndrome","volume":"88","author":"Erdal","year":"2021","journal-title":"Seizure"},{"key":"ref_32","first-page":"e41261","article-title":"Action Myoclonus-Renal Failure Syndrome: A Case Report with Bioinformatic Annotations","volume":"15","author":"Ekmekci","year":"2023","journal-title":"Cureus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000503067","article-title":"Renal Pathological Findings in Action Myoclonus-Renal Failure Syndrome","volume":"144","author":"Desbuissons","year":"2020","journal-title":"Nephron"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1007\/s10072-021-05196-0","article-title":"A Novel Homozygous Splice-Site Mutation in SCARB2 Is Associated with Progressive Myoclonic Epilepsy with Renal Failure","volume":"42","author":"Yari","year":"2021","journal-title":"Neurol Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2022.04.023","article-title":"Action Myoclonus-Renal Failure Syndrome: Electrophysiological Analysis and Clinical Progression of Two Siblings","volume":"99","author":"Tanriverdi","year":"2022","journal-title":"Park. Relat. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"581253","DOI":"10.3389\/fgene.2020.581253","article-title":"Case Report: Distinctive EEG Patterns in SCARB-2 Related Progressive Myoclonus Epilepsy","volume":"11","author":"Hotait","year":"2020","journal-title":"Front. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamaneurol.2016.1553","article-title":"A Rare Cause of Myoclonus: A Cupric Conundrum","volume":"73","author":"Doherty","year":"2016","journal-title":"JAMA Neurol"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/mds.25114","article-title":"A New SCARB2 Mutation in a Patient with Progressive Myoclonus Ataxia without Renal Failure","volume":"27","author":"Serratosa","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.25296","article-title":"A Novel SCARB2 Mutation Causing Late-Onset Progressive Myoclonus Epilepsy","volume":"28","author":"Higashiyama","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/nan.12057","article-title":"Progressive Myoclonus Epilepsy: Extraneuronal Brown Pigment Deposition and System Neurodegeneration in the Brains of Japanese Patients with Novel SCARB2 Mutations","volume":"40","author":"Fu","year":"2014","journal-title":"Neuropathol. Appl. NeuroBiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/cge.12338","article-title":"Using a Combination of Whole-Exome Sequencing and Homozygosity Mapping to Identify a Novel Mutation of SCARB2","volume":"86","author":"He","year":"2014","journal-title":"Clin. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.4103\/0366-6999.235113","article-title":"Identification of a Novel Homozygous Splice-Site Mutation in SCARB2 That Causes Progressive Myoclonus Epilepsy with or without Renal Failure","volume":"131","author":"He","year":"2018","journal-title":"Chin. Med. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.seizure.2018.03.015","article-title":"Progressive Myoclonus Epilepsy without Renal Failure in a Chinese Family with a Novel Mutation in SCARB2 Gene and Literature Review","volume":"57","author":"Tian","year":"2018","journal-title":"Seizure"},{"key":"ref_44","first-page":"143","article-title":"Prosaposin Deficiency: Further Characterization of the Sphingolipid Activator Protein-Deficient Sibs. Multiple Glycolipid Elevations (Including Lactosylceramidosis), Partial Enzyme Deficiencies and Ultrastructure of the Skin in This Generalized Sphingolipid Storage Disease","volume":"92","author":"Roggendorf","year":"1993","journal-title":"Hum. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1016\/S0021-9258(19)50733-5","article-title":"Simultaneous Deficiency of Sphingolipid Activator Proteins 1 and 2 Is Caused by a Mutation in the Initiation Codon of Their Common Gene","volume":"267","author":"Schnabel","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02024331","article-title":"Sphingolipid Activator Protein Deficiency in a 16-Week-Old Atypical Gaucher Disease Patient and His Fetal Sibling: Biochemical Signs of Combined Sphingolipidoses","volume":"149","author":"Harzer","year":"1989","journal-title":"Eur. J. Pediatr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/hmg\/10.9.927","article-title":"A Novel Mutation in the Coding Region of the Prosaposin Gene Leads to a Complete Deficiency of Prosaposin and Saposins, and Is Associated with a Complex Sphingolipidosis Dominated by Lactosylceramide Accumulation","volume":"10","author":"Befekadu","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00695084","article-title":"Niemann-Pick Disease Type C with Enhanced Glycolipid Storage. Report on Further Case of so-Called Lactosylceramidosis","volume":"402","author":"Elleder","year":"1984","journal-title":"Virchows Arch. A"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2005-865608","article-title":"Prosaposin Deficiency\u2014A Rarely Diagnosed, Rapidly Progressing, Neonatal Neurovisceral Lipid Storage Disease. Report of a Further Patient","volume":"36","author":"Elleder","year":"2005","journal-title":"Neuropediatrics"},{"key":"ref_50","first-page":"152","article-title":"Are Sphingolipid Activator Deficiencies Underdiagnosed? Six New Cases Affecting the PSAP Gene Identified in a 3-Years Period","volume":"18","author":"Vanier","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ajmg.a.32712","article-title":"Prosaposin Deficiency and Saposin B Deficiency (Activator-Deficient Metachromatic Leukodystrophy): Report on Two Patients Detected by Analysis of Urinary Sphingolipids and Carrying Novel PSAP Gene Mutations","volume":"149A","author":"Chrastina","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/cge.12753","article-title":"Clinical, Biochemical and Molecular Characterization of Prosaposin Deficiency","volume":"90","author":"Motta","year":"2016","journal-title":"Clin. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1194\/jlr.M043802","article-title":"Action Myoclonus-Renal Failure Syndrome: Diagnostic Applications of Activity-Based Probes and Lipid Analysis","volume":"55","author":"Gaspar","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1405700111","article-title":"LIMP-2 Expression Is Critical for \u03b2-Glucocerebrosidase Activity and \u03b1-Synuclein Clearance","volume":"111","author":"Rothaug","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/hmg\/ddp523","article-title":"Disease-Causing Mutations within the Lysosomal Integral Membrane Protein Type 2 (LIMP-2) Reveal the Nature of Binding to Its Ligand Beta-Glucocerebrosidase","volume":"19","author":"Blanz","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1038\/s41467-019-11425-0","article-title":"Lysosomal Integral Membrane Protein-2 (LIMP-2\/SCARB2) Is Involved in Lysosomal Cholesterol Export","volume":"10","author":"Heybrock","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1515\/bchm3.1986.367.2.879","article-title":"Immunochemical Characterization of Two Activator Proteins Stimulating Enzymic Sphingomyelin Degradation in Vitro. Absence of One of Them in a Human Gaucher Disease Variant","volume":"367","author":"Christomanou","year":"1986","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/BF01716064","article-title":"Activator Protein Deficient Gaucher\u2019s Disease. A Second Patient with the Newly Identified Lipid Storage Disorder","volume":"67","author":"Christomanou","year":"1989","journal-title":"Klin. Wochenschr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(91)80760-Z","article-title":"Mutation in the Sphingolipid Activator Protein 2 in a Patient with a Variant of Gaucher Disease","volume":"284","author":"Schnabel","year":"1991","journal-title":"FEBS Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01233949","article-title":"Mutational Analysis in a Patient with a Variant Form of Gaucher Disease Caused by SAP-2 Deficiency","volume":"19","author":"Rafi","year":"1993","journal-title":"Somat. Cell Mol. Genet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s004010050960","article-title":"Neuronopathic Juvenile Glucosylceramidosis Due to Sap-C Deficiency: Clinical Course, Neuropathology and Brain Lipid Composition in This Gaucher Disease Variant","volume":"97","author":"Pineda","year":"1999","journal-title":"Acta Neuropathol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00439-005-1288-x","article-title":"A Mutation within the Saposin D Domain in a Gaucher Disease Patient with Normal Glucocerebrosidase Activity","volume":"117","author":"Cormand","year":"2005","journal-title":"Hum. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1399-0004.2007.00899.x","article-title":"Non-Neuronopathic Gaucher Disease Due to Saposin C Deficiency","volume":"72","author":"Czartoryska","year":"2007","journal-title":"Clin. Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/hmg\/ddq204","article-title":"Saposin C Mutations in Gaucher Disease Patients Resulting in Lysosomal Lipid Accumulation, Saposin C Deficiency, but Normal Prosaposin Processing and Sorting","volume":"19","author":"Vaccaro","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/jhg.2017.36","article-title":"Successful Newborn Screening for Gaucher Disease Using Fluorometric Assay in China","volume":"62","author":"Kang","year":"2017","journal-title":"J. Hum. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Liaqat, K., Hussain, S., Acharya, A., Nasir, A., Bharadwaj, T., Ansar, M., Basit, S., Schrauwen, I., Ahmad, W., and Leal, S.M. (2022). Phenotype Expansion for Atypical Gaucher Disease Due to Homozygous Missense PSAP Variant in a Large Consanguineous Pakistani Family. Genes, 13.","DOI":"10.3390\/genes13040662"},{"key":"ref_67","first-page":"152","article-title":"Third Case of Gaucher Disease with Sap-C Deficiency and Evaluation of Twelve Months\u2019 Therapy by Miglustat","volume":"28","author":"Amsallem","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_68","first-page":"S147","article-title":"Are Sphingolipid Activator Deficiencies Underdiagnosed?","volume":"47","author":"Vanier","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"31918","DOI":"10.1074\/jbc.M302752200","article-title":"Saposin C Is Required for Normal Resistance of Acid Beta-Glucosidase to Proteolytic Degradation","volume":"278","author":"Sun","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.str.2018.01.007","article-title":"Saposin Lipid Nanoparticles: A Highly Versatile and Modular Tool for Membrane Protein Research","volume":"26","author":"Flayhan","year":"2018","journal-title":"Structure"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s13361-019-02174-x","article-title":"Expanding the Types of Lipids Amenable to Native Mass Spectrometry of Lipoprotein Complexes","volume":"30","author":"Kostelic","year":"2019","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1073\/pnas.1115743109","article-title":"Structure of Saposin A Lipoprotein Discs","volume":"109","author":"Popovic","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1111\/j.1742-4658.2007.05873.x","article-title":"Saposin B Mobilizes Lipids from Cholesterol-Poor and Bis(Monoacylglycero)Phosphate-Rich Membranes at Acidic PH. Unglycosylated Patient Variant Saposin B Lacks Lipid-Extraction Capacity","volume":"274","author":"Remmel","year":"2007","journal-title":"FEBS J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bcmd.2005.10.002","article-title":"Analysis of Nonsense-Mediated MRNA Decay in Mutant Alleles Identified in Spanish Gaucher Disease Patients","volume":"36","author":"Montfort","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER Retention and Degradation as the Molecular Basis Underlying Gaucher Disease Heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/humu.22124","article-title":"Gaucher Disease Paradigm: From ERAD to Comorbidity","volume":"33","author":"Horowitz","year":"2012","journal-title":"Hum. Mutat."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1432-1033.1987.tb11008.x","article-title":"Biosynthesis and Maturation of Glucocerebrosidase in Gaucher Fibroblasts","volume":"164","author":"Jonsson","year":"1987","journal-title":"Eur. J. BioChem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1073\/pnas.85.21.8022","article-title":"Type-C Niemann-Pick Disease: Low Density Lipoprotein Uptake Is Associated with Premature Cholesterol Accumulation in the Golgi Complex and Excessive Cholesterol Storage in Lysosomes","volume":"85","author":"Dwyer","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/cclm-2016-0340","article-title":"Diagnosis of Sphingolipidoses: A New Simultaneous Measurement of Lysosphingolipids by LC-MS\/MS","volume":"55","author":"Polo","year":"2017","journal-title":"Clin. Chem. Lab. Med. (CCLM)"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/12\/6615\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:59:30Z","timestamp":1760108370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/12\/6615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,16]]},"references-count":79,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["ijms25126615"],"URL":"https:\/\/doi.org\/10.3390\/ijms25126615","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,16]]}}}